6 completed, 2 unknown, 1 terminated. 3 Phase 2, 2 Not applicable, 2 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 2 |
Follow focetria: new trials by email Literature Review of focetria trials Research Report on focetria
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection Focetria®, Begrivac® - H1N1 Influenza Virus, Human Immunodeficiency Virus Type 1 (HIV-1) Infection | Phase 3 | Completed | Chiltern Pesquisa Clinica Ltda | 154 | 2010-04-01 | 2013-06-05 |
| Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus Focetria®, Fluad®, Begrivac® - H1N1 Influenza Virus, Chronic Pulmonary Disease | Phase 3 | Completed | Chiltern Pesquisa Clinica Ltda | 342 | 2010-03-01 | 2013-06-14 |
| H1N1sw Vaccine in Adult Transplant Recipients Focetria (2x H1N1 vaccine with MF59 adjuvants) - Immunocompromised | Phase 2 | Terminated | HepNet Study House, German Liverfoundation | 13 | 2010-02-01 | 2012-04-16 |
| Clinical Study to Evaluate Antibody and Cell Mediated Immunity of A/H1N1 Influenza Vaccine in Healthy Subjects egg-derived A/H1N1 pandemic influenza vaccine - Influenza | Phase 4 | Completed | Opera CRO, a TIGERMED Group Company | 7 | 2009-12-01 | 2012-06-01 |
| Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Inflammatory Bowel Diseases (IBD) Treated Immunomodulators and Biologics Focetria (Monovalent MF59-Adjuvanted vaccine) - Influenza H1N1 | Not applicable | Unknown | Tel-Aviv Sourasky Medical Center | 200 | 2009-11-01 | 2009-11-25 |
| H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A H1N1v Vaccination in Pregnant Women Focetria - H1N1v Influenza | Not applicable | Completed | Copenhagen Studies on Asthma in Childhood | 296 | 2009-11-01 | 2022-11-15 |
| Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients Adjuvanted influenza A(H1N1) vaccines - HIV Infection, Rheumatic Disease | Phase 4 | Completed | University Hospital, Geneva | 1141 | 2009-11-01 | 2010-03-01 |
| Vaccination Against Influenza H1N1 in Rheumatic Diseases Focetria (Monovalent MF59-Adjuvanted vaccine) - Influenza, Rheumatic Diseases | Phase 2 | Unknown | Tel-Aviv Sourasky Medical Center | 400 | 2009-11-01 | 2009-11-03 |
| A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine MF59 adjuvanted H1N1 influenza monovalent vaccine, Thymosin alpha 1 - END STAGE RENAL DISEASE | Phase 2 | Completed | sigma-tau i.f.r. S.p.A. | 120 | 2009-11-01 | 2012-03-29 |
Influenza, Human (4) · HIV Infections (2) · Rheumatic Diseases (2) · Acquired Immunodeficiency Syndrome (1) · Arthritis, Psoriatic (1) · Diabetes Mellitus (1) · Heart Diseases (1) · Infections (1) · Kidney Failure, Chronic (1) · Lung Diseases (1) · Neoplasms (1) · Virus Diseases (1)
Chiltern Pesquisa Clinica Ltda (2) · Tel-Aviv Sourasky Medical Center (2) · Copenhagen Studies on Asthma in Childhood (1) · HepNet Study House, German Liverfoundation (1) · Opera CRO, a TIGERMED Group Company (1) · University Hospital, Geneva (1) · sigma-tau i.f.r. S.p.A. (1)
Brazil (2) · Italy (2) · Denmark (1) · Germany (1) · Switzerland (1)
Agostino Naso, MD (1) · Fabio Montanaro, DSc (1) · Franco Laghi Pasini, MD (1) · Iris Dotan, Dr. (1) · Laura Michellini (1) · Michael P Manns, Prof (1)
PMID 21384334, PMID 21419775, PMID 21422117, PMID 21425247, PMID 22228003, PMID 22521851, PMID 22848378, PMID 23637733, PMID 26136476
2009 (2)